Inovio Pharmaceuticals
INO
#9511
Rank
NZ$0.22 B
Marketcap
NZ$2.14
Share price
0.40%
Change (1 day)
-48.79%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -NZ$0.15 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.16 Billion, an increase over its 2024 earnings that were of -NZ$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.15 Billion-2.67%
2025 -NZ$0.16 Billion-15.67%
2024 -NZ$0.19 Billion-20.03%
2023 -NZ$0.23 Billion-51.56%
2022 -NZ$0.47 Billion-8.26%
2021 -NZ$0.51 Billion95.4%
2020 -NZ$0.27 Billion36.62%
2019 -NZ$0.2 Billion20.19%
2018 -NZ$0.16 Billion10.94%
2017 -NZ$0.15 Billion9.59%
2016 -NZ$0.14 Billion118.9%
2015 -NZ$59.71 Million-10.67%
2014 -NZ$66.84 Million83.32%
2013 -NZ$36.46 Million
2011 -NZ$37.62 Million15.64%
2010 -NZ$32.53 Million37.7%
2009 -NZ$23.62 Million2.19%
2008 -NZ$23.12 Million-14.09%
2007 -NZ$26.91 Million19.12%
2006 -NZ$22.59 Million9.62%
2005 -NZ$20.61 Million5.77%
2004 -NZ$19.48 Million73.08%
2003 -NZ$11.26 Million12.75%
2002 -NZ$9.99 Million
2000 -NZ$15.11 Million53.93%
1999 -NZ$9.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$43.96 B-29,892.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$26.70 B-18,200.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$17.92 B-12,245.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$18.15 B-12,402.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.25 B-15,182.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$16.94 B-11,580.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-NZ$4.66 Million-96.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-NZ$0.28 Billion 83.29%๐Ÿ‡บ๐Ÿ‡ธ USA